Search for: "Par Pharmaceutical Companies, Inc."
Results 1 - 20 of 24
Sorted by Relevance | Sort by
Date
23 Jul, 2007 9:13 pm
By Sherri Oslick -- Ortho-McNeil, Inc. announced late last week that it has settled its lawsuit against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc. and Kali Laboratories, Inc., over the patent covering Ortho's Ultracet® (tramadol hydrochloride and acetaminophen, used to
treat acute pain). As part of the...
6 Mar 7:03 am
... conjunction with California's Attorney General, launched its latest challenge to reverse payment settlements in the pharmaceutical
industry, Fed. Trade Comm'n et al. v. Watson Pharm., Inc. et al., 09-cv-00598 (AHM) ("Watson"). In a press release announcing the action ... million in U.S. sales in 2007. The
complaint also names generic pharmaceutical companies Watson Pharmaceuticals, Par
Pharmaceuticals and Paddock Laboratories. Pursuant to the regulatory framework of the Drug Price ...
16 Oct, 2006 7:58 pm
... Andrx's attempt to market generic Cardizem. Novartis sued Par Pharmaceuticals, the third and most recent company to file an
ANDA for generic Lotrel. Schering-Plough sued ... settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. AndroGel, a treatment ... , 2015, which is five years
before Solvay's patent on AndroGel expires. Par will co-promote AndroGel for $10 million a year beginning in 2006 and will.be allowed ...
23 Dec, 2008 7:00 pm
... vote to ratify the compensation of named executive officers was adopted by the Board of Directors of Blockbuster Inc. It was withdrawn at Par Pharmaceuticals based on the Board of Directors' commitment to adopt the policy in 2009. Social and Environmental ... company operations,
based on current emerging technologies, was adopted by Williams Companies, Inc. Five companies adopted a proposal that asked selected companies to report on
their policies and procedures for minimizing customer exposure to ...
18 Oct 5:42 pm
... district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay's branded
testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. "At a time [...]... Senate
Bill Would Prevent Reverse Pharma PaymentsThe Patent Docs are reporting that on ...
29 Oct, 2008 12:14 pm
... of June 30, 2008, shareholders at only a few companies have actually approved say-on-pay proposals, including Apple Inc., PG&E Corporation, Tech Data ...
implemented say on pay during the 2008 proxy season: Aflac, Inc., Risk Metrics Group Inc., and Littlefield Corporation. As the report noted: "Aflac put its entire ... 2007
comepnsation payouts and 2008 performance objectives." At least thee companies (Par Pharmaceutical Companies, MBIA and Blockbuster) have committed to providing an advisory vote ...
10 Mar, 2008 1:10 pm
... Claudia Mason (hereinafter, the Masons) sued The Home Depot U.S.A., Inc. and The Flecto Company, Inc. in 1997 for injuries Arvin Mason allegedly received in
1996 while using ... trial court as error: applying the standards identified in Daubert v. Merrell Dow Pharmaceuticals, Inc., supra, and concluding that the Masons' expert
witnesses, Dr. Ziem and ... these powers "remain forever separate and distinct." Art. I, Sec. II, Par. III . As we have long recognized, "[i]n
the dividing line of power between ...
22 Jan 2:06 am
... (N.D.N.Y. Jul. 19, 2006); Laisure-Radke v. Par Pharmaceutical, Inc., 2006 WL 901657, at *4
(W.D. Wash. Mar. 29, ... generic drug should be better off - with an extra cause of action against a non-manufacturing pharmaceutical
company - than an identical plaintiff who took a pioneer drug. Cf. Ramirez, 6 Cal ... those trials uncover a serious safety problem, with liability divorced from manufacture, the
pioneer company conducting the studies could end up saddled with liability for irresponsible off-label ...
2 Nov, 2007 11:00 pm
... Seoul Semiconductor wins appeal for damages and injunction against Itswell: (Semiconductor today), Poland Ranbaxy sues Polish company over registration of 'ranbaxy.ed', but
in the Delhi High Court...: (Poland-IP law), Google wins gmail.com.pl ... law-suits against a total of 25 defendants for infringing their patents for flash memory: (IPFactor), (Philip
Brooks), Par Pharmaceuticals appetite stimulant patent (for liquids containing megestrol acetate) still invalid as lacking Enablement
under 112 on ...
20 Mar 2:05 am
... effects suffered by the plaintiff. Id. at 480. There are lots of rationales for why drug companies (and device and vaccine makers, too) shouldn't be liable for not ... 5th
Cir. 1988). Maine: Porter v. Pfizer Hospital Products Group, Inc., 783 F.Supp. 1466, 1475 (D. Me. 1992). Maryland: Gourdine ... W.2d 623, 627-28 (Mo. 1968); Meyer v. Astrazeneca
Pharmaceuticals, L.P., 224 S.W.3d 106, 108 (Mo. App ... 770 (W.D. Va. 1980). Washington: Laisure-Radke v. Par Pharmaceutical, Inc., 426 F.Supp.2d 1163, 1172-73 (W.D ...
27 Feb 5:00 am
... (SmartBrief) US: Discussion of NYT article 'Crop Scientists Say Biotechnology Seed Companies are Thwarting Research' (Patent Docs) (Patent Baristas) US FDA: Genetically
engineered ... marketing of Modified Sequential Screening protocol: Intema Ltd v NTD Laboratories, Inc et al (Patent Docs) US: District Court Delaware: Motion to dismiss ...
patent infringement following Teva's Para IV certification as part of ANDA for generic Integrilin: Millennium Pharmaceuticals Inc. et al. v. Teva Parenteral Medicines ...
2 May, 2008 7:00 am
... (FDA Law Blog), Rythmol (Propafenone) - US: Court rules Frommer can defend Par Pharmaceuticals in Rythmol patent suit despite their
earlier work with Reliant ... rules that myspace.co.uk domain does not need to be transferred to MySpace Inc, owners of myspace.com social networking site: (IPKat), Critics brand
Phorm a regulatory ... Companies / Entities Al Minor & Assoc - memorizing information, including specifically client lists, constitutes trade secret misappropriation: Al
Minor & Assoc, Inc ...
3 Jun 5:49 am
... Tech (Patently-O) US: Pharmasset sued for patent infringement over its development of pharmaceutical compositions through the use of the
TET system: TET System Holding GmbH & ... Pharmasset, Inc (Patent Docs) US: Mylan's Chief Officer to testify before Congress concerning patent settlements between brand and
generic pharmaceutical companies ... between PREOS and PROTOS for osteoporosis medications: NPS Pharmaceuticals, Inc v
Biofarma, Société Par Actions Simplifiée (Canadian Trademark Blog) Protonix ...
3 Jun 5:49 am
... Tech (Patently-O) US: Pharmasset sued for patent infringement over its development of pharmaceutical compositions through the use of the
TET system: TET System Holding GmbH & ... Pharmasset, Inc (Patent Docs) US: Mylan's Chief Officer to testify before Congress concerning patent settlements between brand and
generic pharmaceutical companies ... between PREOS and PROTOS for osteoporosis medications: NPS Pharmaceuticals, Inc v
Biofarma, Société Par Actions Simplifiée (Canadian Trademark Blog) Protonix ...
28 Apr, 2008 11:00 am
... ) - US FTC turns to federal court to get executives to comply with subpoenas as part of investigation into whether Par Pharmaceutical, Paddlock Laboratories and others restrained trade for marketing generic Androgel: (IP Law360), Astelin and ... Association of Broadcasters
seeks new copyright exception: (Michael Geist), Government of Alberta announces economic measures for tech companies: (ipblog.ca), Where do the Liberals stand on copyright?:
(Michael Geist) China The law and new tech in China: ( ...
17 Jan, 2008 7:55 am
... s no conflict with FDA regulation, this argument goes, because under that regulation, the defendant pharmaceutical company could
always add or strengthen its warning without prior FDA approval - ... courts have accepted this §314.70(c)(6)(iii) argument and ruled that pharmaceutical defendants should have unilaterally strengthened suicide warnings for antidepressants - despite the FDA having ... .2d 964, 968 (D. Neb. 2006);
Laisure-Radke v. Par Pharmaceutical, Inc., 2006 WL 901657, at *4-5 (W.D. Wash. Mar. ...
8 Jul 7:04 am
... ) General IP Think Tank podcast 2 July 2009 including discussion of pharmaceutical and biological data exclusivity in the US and Brazil (IP
Think Tank) ... and biological sequencing in Brazil (IP tango) East Africa: Report: Drug companies violating WHO ethics on advertising in East Africa (Intellectual Property
Watch) India: US- ... , Travatan Z (Travoprost) - US: Alcon files patent infringement suit against Par Pharmaceuticals following ANDA to
manufacture generic versions of Travatan and Travatan Z ( ...
27 Mar 8:00 am
... 13 generic companies over Levofloxacin (GenericsWeb) Lovaza (Omega 3) - US: Pronova BioPharma receives Lovaza para IV notice letter from Par Pharmaceutical (GenericsWeb) ... Astra Zeneca's patent (Spicy IP) Primacare One - US: KV Pharmaceutical set to pull Primacare One prenatal vitamin supplement from the market; Lannett ends ... IPO follows Takeda in decision on SPC application on
combination product: Astellas Pharma Inc's application (The SPC Blog) Risperdal (Resperidone) - US: Supreme Court denies ...
22 Apr 6:14 am
Citigroup has been hit with a $30 million auction-rate securities lawsuit filed by Braintree Laboratories, Inc., a specialty pharmaceutical company, reported Christine Caufield in an April 17, 2009 article posted on Law360.com. The suit comes ... without identifying them as
such, instead characterizing them as government-backed money market investments that could be sold at par at any time on seven days notice. In
reality, Braintree alleges, these instruments were illiquid auction-rate securities, ...
8 May 8:00 am
... IP) Brazil tightens rules on drug companies' influence on physicians (Intellectual Property Watch) Poland: Average consumer and advertising of pharmaceutical products (Class 46) US: ... has exclusive right to the subject matter: Sun Pacific Farming Co-op, Inc v Sun World Intern. (Property
intangible) US: Supreme Court rules 9-0 ... -grant opposition filed by Cipla (Patent Circle) Treximet (Sumatriptan, Naproxen) - US: Par drops
GSK from Treximet suit (Patent Docs) Triptorelin - Germany: Federal Patent ...
Search on: Blawgs.FM | BlawgSearch Google
Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!